全球豬環狀病毒疫苗市場規模（按疫苗類型、最終用戶、分銷管道、區域覆蓋範圍和預測）

豬環狀病毒疫苗的市場規模及預測

豬環狀病毒疫苗的市場規模近年來快速成長，市場估計和預測預計將在2026年至2032年間大幅成長。

推動全球豬環狀病毒疫苗市場的因素

豬環狀病毒疫苗市場的促進因素受多種因素影響。其中包括：

• 豬肉消費量不斷成長：隨著全球豬肉需求的增加，對有效疫苗接種以預防豬環狀病毒等疾病的需求也在增加。在經濟擴張和飲食偏好變化的國家，豬肉消費量也不斷成長，這刺激了疫苗接種的需求。
• 豬環狀病毒疫情：圓環病毒感染會導致豬隻生長速度下降、飼料轉換率低和死亡率上升，進而對養豬業造成重大經濟損失。圓環病毒的危害及其在豬群中的流行，使得疫苗接種成為預防和控制的必要措施。
• 政府立法與支持：政府立法強制推行疫苗接種計劃，並為牲畜疾病管制提供支持，這些立法對豬環狀病毒疫苗的推廣有重大影響。一些地區可能提供補貼和其他激勵措施，鼓勵農民為豬隻接種疫苗，擴大市場。
• 教育與意識提升：提高養豬戶對接種疫苗以預防PCV等疾病益處的認知，可以促進市場擴張。為了推廣最佳養豬實踐，宣傳宣傳活動、研討會和培訓課程經常強調疫苗接種作為預防措施的價值。
• 技術發展：疫苗技術的進步，例如更安全、更有效的疫苗製劑的開發，可能會增加農民對豬環狀病毒疫苗接種的興趣。佐劑、疫苗平台和新的給藥技術可能會提高疫苗接種的有效性、免疫持續時間和給藥的便利性。
• 疾病爆發和生物安全問題：為應對豬環狀病毒相關感染疾病和其他影響豬群的感染疾病爆發，可能需要加強疫苗接種宣傳活動並制定更嚴格的生物安全通訊協定。隨著農民為防止疾病的傳入和傳播而更積極地接種疫苗，對圓環病毒疫苗的需求可能會增加。
• 養豬業的成長：養豬業的成長可能會增加對豬環狀病毒疫苗的需求。生豬數量的增加和密集生產方式的推行，可能會導致人們更加依賴疫苗接種作為疾病控制技術。

限制全球豬環狀病毒疫苗市場的因素

豬環狀病毒病毒疫苗市場面臨多種限制與挑戰，包括：

• 監管障礙：監管障礙：嚴格的法規和漫長的核准流程可能會延遲新疫苗的推出。
• 高昂的研發成本：臨床試驗和合規成本只是疫苗生產相關的主要研發支出中的兩項。這些高昂的價格可能會阻礙中小企業進入市場，並限制價格實惠的疫苗供應。
• 知識匱乏：養豬戶可能尚未充分了解豬環狀病毒疫苗接種的益處，這可能會阻礙市場擴張。推廣和教育計畫對於提高疫苗接種率至關重要。
• 競爭格局：尋求市場佔有率的新參與企業可能會面臨挑戰，因為存在替代治療方法，現有疫苗製造商面臨激烈競爭。
• 原料短缺或分銷困難等供應鏈問題可能會影響疫苗的取得和市場擴張。
• 生物安全問題：透過生物安全措施預防疾病爆發，一些地區的養豬戶可能覺得沒有必要接種疫苗，從而減少了市場需求。
• 疫苗有效性：由於疫苗有效性因豬環狀病毒株而異，農民可能會對目前可用的疫苗的效率失去信心，從而影響採用率。
• 道德和環境問題：少數客戶和倡導團體可能會對動物農業中疫苗的使用提出道德問題，這可能會影響立法和公眾輿論。

目錄

第1章 引言

• 市場定義
• 市場區隔
• 調查方法

第2章執行摘要

• 主要發現
• 市場概覽
• 市場亮點

第3章市場概述

• 市場規模和成長潛力
• 市場趨勢
• 市場促進因素
• 市場限制
• 市場機會
• 波特五力分析

第4章豬環狀病毒病毒疫苗市場（依疫苗類型）

• PCV1疫苗
• PCV2疫苗

第5章豬環狀病毒疫苗市場（依最終用戶）

• 養豬場
• 獸醫診所

第6章豬環狀病毒疫苗市場（依通路）

• 直銷
• 經銷商銷售

第7章區域分析

• 北美洲
• 美國
• 加拿大
• 墨西哥
• 歐洲
• 英國
• 德國
• 法國
• 義大利
• 亞太地區
• 中國
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中東和非洲
• 南非
• 沙烏地阿拉伯
• 阿拉伯聯合大公國

第8章市場動態

• 市場促進因素
• 市場限制
• 市場機會
• COVID-19 市場影響

第9章 競爭態勢

• 主要企業
• 市場佔有率分析

第10章 公司簡介

• DHN
• Komipharm
• Qilu Animal
• Chopper Biology
• Ringpu Biology
• ChengDu Tecbond
• Jinyu Bio-Technology
• Zoetis
• Merial
• CAVAC
• Merck
• Elanco Animal Health

第11章 市場展望與機會

• 新興技術
• 未來市場趨勢
• 投資機會

第12章 附錄

• 簡稱列表
• 來源和參考文獻

Porcine Circovirus Vaccine Market Size And Forecast

Porcine Circovirus Vaccine Market size is growing at a faster pace with substantial growth rates over the last few years and is estimated that the Market will grow significantly in the forecasted period i.e., 2026 to 2032.

Global Porcine Circovirus Vaccine Market Drivers

The market drivers for the Porcine Circovirus Vaccine Market can be influenced by various factors. These may include:

• Growing Pork Consumption: The need for efficient vaccinations to prevent diseases like porcine circovirus is growing along with the world's demand for pork. Pork consumption frequently rises in nations with expanding economies and shifting dietary preferences, which fuels the need for vaccinations.
• Porcine Circovirus Prevalence: PCV infections can cause large financial losses for the swine industry because of decreased growth rates, inadequate feed conversion, and elevated mortality rates. The use of vaccinations for prevention and control is required due to the negative effects of PCV and its prevalence in pig herds.
• Government legislation and Support: The adoption of porcine circovirus vaccines can be greatly impacted by government legislation requiring vaccination programmes or offering assistance for disease control in animals. Subsidies or other rewards might be provided in some areas to entice farmers to vaccinate their pigs, expanding the market.
• Education and Awareness: Raising pig farmers' knowledge of the advantages of immunisation in avoiding illnesses like PCV can spur market expansion. In order to promote optimal practices in pig farming, awareness campaigns, seminars, and training courses frequently stress the value of vaccination as a preventative approach.
• Technological developments: Improvements in vaccine technology, such as the creation of safer and more effective vaccine formulations, can increase farmers' interest in pig circovirus vaccinations. Adjuvants, vaccine platforms, and new delivery techniques may enhance vaccination efficacy, immunity duration, and administration simplicity.
• Disease Outbreaks and Biosecurity Concerns: Increased vaccination campaigns and stricter biosecurity protocols may be necessary in response to outbreaks of infectious diseases linked to the porcine circovirus or other diseases affecting pig populations. Demand for PCV vaccines may be increased if farmers vaccinate their herds proactively to stop the introduction and spread of illnesses.
• Growth in the Pig Farming business: The demand for porcine circovirus vaccines may increase if the pig farming business grows, especially in emerging nations or areas where agricultural methods are changing. An increased reliance on vaccination as a disease management technique could result from growing pig populations and more intensive production practices.

Global Porcine Circovirus Vaccine Market Restraints

Several factors can act as restraints or challenges for the Porcine Circovirus Vaccine Market. These may include:

• Regulatory Obstacles: Tight regulations and lengthy approval procedures may cause delays in the release of novel vaccinations, which would reduce their potential for expansion.
• High Cost of Development: Conducting clinical trials and paying for regulatory compliance are just two of the major research and development expenses associated with creating vaccines. These exorbitant prices may discourage smaller businesses from entering the market and restrict the supply of reasonably priced vaccinations.
• Limited Knowledge: The advantages of porcine circovirus vaccinations may not be well understood by pig producers, which could impede market expansion. It could be essential to conduct outreach and education programmes to raise adoption rates.
• Competitive Landscape: New entrants attempting to gain market share may face difficulties due to the presence of other therapeutic options and fierce competition from incumbent vaccine makers.
• Problems with the supply chain, such as shortages of raw materials or difficulties with distribution, can have an effect on the accessibility of vaccines and the expansion of the market.
• Biosecurity Concerns: By preventing disease outbreaks through biosecurity measures, pig farmers may be able to lower the perceived need for vaccines in some areas, which would decrease market demand.
• Vaccine Efficacy: Vaccine efficacy varies amongst strains of porcine circovirus, which might cause farmers to lose faith in the efficiency of currently available vaccinations and thus influence adoption rates.
• Ethical and Environmental Concerns: A few customers and advocacy groups may bring up moral questions with the use of vaccines in cattle production, which may have an impact on laws or public opinion.

Global Porcine Circovirus Vaccine Market Segmentation Analysis

The Global Porcine Circovirus Vaccine Market is Segmented on the basis of Vaccine Type, End User, Distribution Channel, and Geography.

Porcine Circovirus Vaccine Market, By Vaccine Type

• PCV1 Vaccine: Vaccines targeting Porcine Circovirus Type 1.
• PCV2 Vaccine: Vaccines targeting Porcine Circovirus Type 2.

Porcine Circovirus Vaccine Market, By End User

• Swine Farms: Large-scale pig farming operations responsible for raising swine for commercial purposes.
• Veterinary Clinics: Healthcare facilities specializing in animal care and treatment, including vaccination services.

Porcine Circovirus Vaccine Market, By Distribution Channel

• Direct Sales: Sales directly from the manufacturer to end-users or large-scale distributors.
• Distributor Sales: Sales through intermediary distributors or wholesalers to reach retail outlets or end-users.

Porcine Circovirus Vaccine Market, By Geography

• North America: Market conditions and demand in the United States, Canada, and Mexico.
• Europe: Analysis of the Porcine Circovirus Vaccine Market in European countries.
• Asia-Pacific: Focusing on countries like China, India, Japan, South Korea, and others.
• Middle East and Africa: Examining market dynamics in the Middle East and African regions.
• Latin America: Covering market trends and developments in countries across Latin America.

Key Players

• The major players in the Porcine Circovirus Vaccine Market are:
• DHN
• Komipharm
• Qilu Animal
• Chopper Biology
• Ringpu Biology
• ChengDu Tecbond
• Jinyu Bio-Technology
• Zoetis
• Merial
• CAVAC
• Merck
• Elanco Animal Health

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Porcine Circovirus Vaccine Market, By Vaccine Type

• PCV1 Vaccine
• PCV2 Vaccine

5. Porcine Circovirus Vaccine Market, By End User

• Swine Farms
• Veterinary Clinics

6. Porcine Circovirus Vaccine Market, By Distribution Channel

• Direct Sales
• Distributor Sales

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• DHN
• Komipharm
• Qilu Animal
• Chopper Biology
• Ringpu Biology
• ChengDu Tecbond
• Jinyu Bio-Technology
• Zoetis
• Merial
• CAVAC
• Merck
• Elanco Animal Health

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References